Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Periodicals
Apple approves return of Parler to App Store, CNN reports » 12:28
04/19/21
04/19
12:28
04/19/21
12:28
AAPL

Apple

$134.32 /

+0.2 (+0.15%)

Apple will allow Parler,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AAPL Apple
$134.32 /

+0.2 (+0.15%)

AAPL Apple
$134.32 /

+0.2 (+0.15%)

09:33 Today Needham
Kulicke & Soffa initiated with a Buy at Needham
08:14 Today Wedbush
Wedbush expecting new Apple iPad launches 'with a few surprises' this week
04/14/21 Evercore ISI
Apple added to Tactical Outperform list at Evercore ISI
04/13/21 Wedbush
Facebook assumed with Neutral at Wedbush, cites privacy risk
AAPL Apple
$134.32 /

+0.2 (+0.15%)

AAPL Apple
$134.32 /

+0.2 (+0.15%)

AAPL Apple
$134.32 /

+0.2 (+0.15%)

AAPL Apple
$134.32 /

+0.2 (+0.15%)

Hot Stocks
Microsoft to start testing cloud gaming for Windows 10 PCs, iOS devices » 11:56
04/19/21
04/19
11:56
04/19/21
11:56
MSFT

Microsoft

$259.73 /

-0.85 (-0.33%)

, AAPL

Apple

$134.63 /

+0.51 (+0.38%)

Microsoft (AAPL) said…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MSFT Microsoft
$259.73 /

-0.85 (-0.33%)

AAPL Apple
$134.63 /

+0.51 (+0.38%)

MSFT Microsoft
$259.73 /

-0.85 (-0.33%)

08:12 Today Morgan Stanley
Morgan Stanley reiterates Microsoft as a Top Pick ahead of earnings
04/13/21 Morgan Stanley
Morgan Stanley says Microsoft 'uniquely positioned' for synergies with Nuance
04/13/21 Craig-Hallum
Nuance downgraded to Hold from Buy at Craig-Hallum
04/13/21 Wedbush
Nuance downgraded to Neutral at Wedbush on Microsoft deal
AAPL Apple
$134.63 /

+0.51 (+0.38%)

09:33 Today Needham
Kulicke & Soffa initiated with a Buy at Needham
08:14 Today Wedbush
Wedbush expecting new Apple iPad launches 'with a few surprises' this week
04/14/21 Evercore ISI
Apple added to Tactical Outperform list at Evercore ISI
04/13/21 Wedbush
Facebook assumed with Neutral at Wedbush, cites privacy risk
MSFT Microsoft
$259.73 /

-0.85 (-0.33%)

AAPL Apple
$134.63 /

+0.51 (+0.38%)

MSFT Microsoft
$259.73 /

-0.85 (-0.33%)

AAPL Apple
$134.63 /

+0.51 (+0.38%)

MSFT Microsoft
$259.73 /

-0.85 (-0.33%)

AAPL Apple
$134.63 /

+0.51 (+0.38%)

MSFT Microsoft
$259.73 /

-0.85 (-0.33%)

AAPL Apple
$134.63 /

+0.51 (+0.38%)

On The Fly
Vizio rises as Wall Street analysts roll out bullish coverage » 10:58
04/19/21
04/19
10:58
04/19/21
10:58
VZIO

Vizio

$24.37 /

+0.07 (+0.29%)

, ROKU

Roku

$364.48 /

-11.95 (-3.17%)

, WMT

Walmart

$139.85 /

-0.64 (-0.46%)

, TGT

Target

$209.69 /

+1.115 (+0.53%)

Several Wall Street…

ShowHide Related Items >><<
VZIO Vizio
$24.37 /

+0.07 (+0.29%)

ROKU Roku
$364.48 /

-11.95 (-3.17%)

WMT Walmart
$139.85 /

-0.64 (-0.46%)

TGT Target
$209.69 /

+1.115 (+0.53%)

VZIO Vizio
$24.37 /

+0.07 (+0.29%)

10:14 Today Wells Fargo
Vizio initiated with an Overweight at Wells Fargo
09:53 Today
Fly Intel: Top five analyst initiations
09:29 Today Needham
Vizio initiated with a Buy at Needham
07:56 Today Roth Capital
Vizio initiated with a Buy at Roth Capital
ROKU Roku
$364.48 /

-11.95 (-3.17%)

09:29 Today Needham
Vizio initiated with a Buy at Needham
04/08/21 Deutsche Bank
Roku 20% pullback good buying opportunity, says Deutsche Bank
04/05/21 Evercore ISI
Roku initiated with an Outperform at Evercore ISI
03/30/21
Fly Intel: Top five analyst upgrades
WMT Walmart
$139.85 /

-0.64 (-0.46%)

04/06/21 Morgan Stanley
Walmart+ membership 'seems to have stagnated,' says Morgan Stanley
03/16/21 MKM Partners
Walmart price target lowered to $141 from $154 at MKM Partners
02/23/21 Evercore ISI
Walmart accelerating change with investments, says Evercore ISI
02/19/21 Morgan Stanley
Walmart terminal value rising with investments, says Morgan Stanley
TGT Target
$209.69 /

+1.115 (+0.53%)

07:31 Today JPMorgan
Target price target raised to $230 from $210 at JPMorgan
03/31/21 Guggenheim
Target price target raised to $225 from $200 at Guggenheim
03/30/21 Stifel
Target price target raised to $230 from $220 at Stifel
03/16/21 MKM Partners
Target price target raised to $170 from $156 at MKM Partners
ROKU Roku
$364.48 /

-11.95 (-3.17%)

WMT Walmart
$139.85 /

-0.64 (-0.46%)

TGT Target
$209.69 /

+1.115 (+0.53%)

  • 25
    Mar
ROKU Roku
$364.48 /

-11.95 (-3.17%)

WMT Walmart
$139.85 /

-0.64 (-0.46%)

TGT Target
$209.69 /

+1.115 (+0.53%)

VZIO Vizio
$24.37 /

+0.07 (+0.29%)

ROKU Roku
$364.48 /

-11.95 (-3.17%)

WMT Walmart
$139.85 /

-0.64 (-0.46%)

TGT Target
$209.69 /

+1.115 (+0.53%)

VZIO Vizio
$24.37 /

+0.07 (+0.29%)

ROKU Roku
$364.48 /

-11.95 (-3.17%)

WMT Walmart
$139.85 /

-0.64 (-0.46%)

TGT Target
$209.69 /

+1.115 (+0.53%)

Periodicals
J&J affirms 100M vaccine commitment in U.S. to CNBC » 10:47
04/19/21
04/19
10:47
04/19/21
10:47
JNJ

Johnson & Johnson

$162.14 /

-0.01 (-0.01%)

, EBS

Emergent BioSolutions

$70.88 /

-6.77 (-8.72%)

Johnson & Johnson…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JNJ Johnson & Johnson
$162.14 /

-0.01 (-0.01%)

EBS Emergent BioSolutions
$70.88 /

-6.77 (-8.72%)

JNJ Johnson & Johnson
$162.14 /

-0.01 (-0.01%)

09:14 Today Chardan
Chardan sees J&J moving forward with Emergent if observations are minor
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
EBS Emergent BioSolutions
$70.88 /

-6.77 (-8.72%)

04/07/21
Fly Intel: Top five analyst initiations
04/07/21 Benchmark
Benchmark starts Emergent at Buy, thinks shares can resume upward momentum
JNJ Johnson & Johnson
$162.14 /

-0.01 (-0.01%)

EBS Emergent BioSolutions
$70.88 /

-6.77 (-8.72%)

JNJ Johnson & Johnson
$162.14 /

-0.01 (-0.01%)

EBS Emergent BioSolutions
$70.88 /

-6.77 (-8.72%)

JNJ Johnson & Johnson
$162.14 /

-0.01 (-0.01%)

EBS Emergent BioSolutions
$70.88 /

-6.77 (-8.72%)

JNJ Johnson & Johnson
$162.14 /

-0.01 (-0.01%)

Initiation
Kulicke & Soffa initiated with a Buy at Needham » 09:33
04/19/21
04/19
09:33
04/19/21
09:33
KLIC

Kulicke & Soffa

$54.33 /

+1.14 (+2.14%)

, AAPL

Apple

$134.15 /

-0.34 (-0.25%)

Needham analyst Charles…

Needham analyst Charles Shi initiated coverage of Kulicke & Soffa (KLIC) with a Buy rating and $64 price target. The company is the market leader in wire bonder equipment, which packages about 80% of the world's semiconductor units, the analyst tells investors in a research note. Shi adds that Kulicke & Soffa has recently diversified into advanced display, including mini- and micro-LEDs, and given that Apple (AAPL) will soon introduce new iPad models with mini-LED displays, he anticipates the multi-year demand growth for mini-LED assembly equipment to benefit directly.

ShowHide Related Items >><<
KLIC Kulicke & Soffa
$54.33 /

+1.14 (+2.14%)

AAPL Apple
$134.15 /

-0.34 (-0.25%)

KLIC Kulicke & Soffa
$54.33 /

+1.14 (+2.14%)

01/20/21 Craig-Hallum
Kulicke & Soffa price target raised to $55 from $40 at Craig-Hallum
12/14/20 B. Riley
Kulicke & Soffa price target raised to $44 from $38 at B. Riley Securities
11/20/20 DA Davidson
Kulicke & Soffa price target raised to $40 from $33 at DA Davidson
11/20/20 B. Riley
Kulicke & Soffa price target raised to $38 from $36 at B. Riley Securities
AAPL Apple
$134.15 /

-0.34 (-0.25%)

08:14 Today Wedbush
Wedbush expecting new Apple iPad launches 'with a few surprises' this week
04/14/21 Evercore ISI
Apple added to Tactical Outperform list at Evercore ISI
04/13/21 Wedbush
Facebook assumed with Neutral at Wedbush, cites privacy risk
04/12/21 Canaccord
Canaccord upgrades Tesla with over $1,000 target on 'Apple-esque' ecosystem
KLIC Kulicke & Soffa
$54.33 /

+1.14 (+2.14%)

AAPL Apple
$134.15 /

-0.34 (-0.25%)

AAPL Apple
$134.15 /

-0.34 (-0.25%)

AAPL Apple
$134.15 /

-0.34 (-0.25%)

AAPL Apple
$134.15 /

-0.34 (-0.25%)

Conference/Events
American Academy of Neurology to hold a virtual meeting » 09:24
04/19/21
04/19
09:24
04/19/21
09:24
ABBV

AbbVie

$107.93 /

+1.05 (+0.98%)

, ABC

AmerisourceBergen

$119.62 /

+0.55 (+0.46%)

, ABT

Abbott

$124.37 /

+0.4 (+0.32%)

, ACAD

Acadia Pharmaceuticals

$21.17 /

-0.02 (-0.09%)

, ALNY

Alnylam

$138.69 /

-0.23 (-0.17%)

, BIIB

Biogen

$270.07 /

-0.66 (-0.24%)

, BMY

Bristol-Myers

$65.46 /

+1.02 (+1.58%)

, BHVN

Biohaven Pharmaceutical

$74.37 /

-1.435 (-1.89%)

, CPRX

Catalyst Pharmaceuticals

$4.44 /

-0.02 (-0.45%)

, DGX

Quest Diagnostics

$130.09 /

+0.86 (+0.67%)

, DNA

Bought by RHHBY

$94.97 /

+ (+0.00%)

, HZNP

Horizon Therapeutics

$93.25 /

-0.32 (-0.34%)

, LIVN

LivaNova

$81.37 /

-1.46 (-1.76%)

, LLY

Eli Lilly

$189.25 /

+3.28 (+1.76%)

, MDT

Medtronic

$125.91 /

+0.06 (+0.05%)

, NVS

Novartis

$88.02 /

+0.81 (+0.93%)

, NVTA

Invitae

$37.65 /

-1.47 (-3.76%)

, PFE

Pfizer

$38.57 /

+0.96 (+2.55%)

, PTCT

PTC Therapeutics

$48.48 /

+0.33 (+0.69%)

, RETA

Reata Pharmaceuticals

$90.83 /

-1.29 (-1.40%)

, SNY

Sanofi

$51.29 /

+0.63 (+1.24%)

, SUPN

Supernus

$31.72 /

-0.09 (-0.28%)

, TAK

Takeda Pharmaceutical

$17.08 /

-0.13 (-0.76%)

, TEVA

Teva

$10.75 /

-0.08 (-0.74%)

, TGTX

TG Therapeutics

$44.79 /

-1.05 (-2.29%)

, ZGNX

Zogenix

$19.00 /

-0.65 (-3.31%)

, AVDL

Avadel Pharmaceuticals

$8.65 /

+0.09 (+1.05%)

, JNJ

Johnson & Johnson

$162.24 /

+1.74 (+1.08%)

73rd Annual Virtual…

73rd Annual Virtual Meeting of AAN will be held on April 17-22. Webcast Link

ShowHide Related Items >><<
ZGNX Zogenix
$19.00 /

-0.65 (-3.31%)

TGTX TG Therapeutics
$44.79 /

-1.05 (-2.29%)

TEVA Teva
$10.75 /

-0.08 (-0.74%)

TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

SUPN Supernus
$31.72 /

-0.09 (-0.28%)

SNY Sanofi
$51.29 /

+0.63 (+1.24%)

RETA Reata Pharmaceuticals
$90.83 /

-1.29 (-1.40%)

PTCT PTC Therapeutics
$48.48 /

+0.33 (+0.69%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

NVTA Invitae
$37.65 /

-1.47 (-3.76%)

NVS Novartis
$88.02 /

+0.81 (+0.93%)

MDT Medtronic
$125.91 /

+0.06 (+0.05%)

LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

LIVN LivaNova
$81.37 /

-1.46 (-1.76%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

HZNP Horizon Therapeutics
$93.25 /

-0.32 (-0.34%)

DGX Quest Diagnostics
$130.09 /

+0.86 (+0.67%)

CPRX Catalyst Pharmaceuticals
$4.44 /

-0.02 (-0.45%)

BMY Bristol-Myers
$65.46 /

+1.02 (+1.58%)

BIIB Biogen
$270.07 /

-0.66 (-0.24%)

BHVN Biohaven Pharmaceutical
$74.37 /

-1.435 (-1.89%)

AVDL Avadel Pharmaceuticals
$8.65 /

+0.09 (+1.05%)

ALNY Alnylam
$138.69 /

-0.23 (-0.17%)

ACAD Acadia Pharmaceuticals
$21.17 /

-0.02 (-0.09%)

ABT Abbott
$124.37 /

+0.4 (+0.32%)

ABC AmerisourceBergen
$119.62 /

+0.55 (+0.46%)

ABBV AbbVie
$107.93 /

+1.05 (+0.98%)

ABBV AbbVie
$107.93 /

+1.05 (+0.98%)

04/06/21 RBC Capital
AbbVie transferred with an Outperform at RBC Capital
04/01/21 Piper Sandler
Integra to benefit from FDA safety communication, says Piper Sandler
04/01/21 Piper Sandler
Piper migraine survey bearish for Amgen, bullish for Biohaven
03/17/21 JPMorgan
AbbVie selloff on Rinvoq deal 'appears overdone,' says JPMorgan
ABC AmerisourceBergen
$119.62 /

+0.55 (+0.46%)

03/09/21 Baird
AmerisourceBergen remains top pick following results, says Baird
02/09/21 Mizuho
AmerisourceBergen price target raised to $114 from $104 at Mizuho
02/08/21 Cowen
AmerisourceBergen price target raised to $150 from $145 at Cowen
02/04/21 Evercore ISI
AmerisourceBergen upgraded to Outperform after Q1 report at Evercore ISI
ABT Abbott
$124.37 /

+0.4 (+0.32%)

04/15/21 Atlantic Equities
Atlantic Equities starts Abbott at Neutral
04/15/21 Atlantic Equities
Abbott initiated with a Neutral at Atlantic Equities
03/16/21 Piper Sandler
Abbott study challenging Abiomed's Impella halted, says Piper Sandler
03/10/21 Wells Fargo
Wells says Quidel Covid testing comments not a direct read through to Abbott
ACAD Acadia Pharmaceuticals
$21.17 /

-0.02 (-0.09%)

04/07/21 Needham
Acadia price target lowered to $30 from $44 at Needham
04/07/21 H.C. Wainwright
Acadia downgraded to Neutral from Buy at H.C. Wainwright
04/06/21 SVB Leerink
Acadia price target lowered to $31 from $63 at SVB Leerink
04/06/21 Jefferies
Acadia downgraded to Hold at Jefferies after dementia-related psychosis CRL
ALNY Alnylam
$138.69 /

-0.23 (-0.17%)

02/22/21 Guggenheim
Alnylam downgraded to Neutral from Buy at Guggenheim
02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 Barclays
Alnylam price target raised to $196 from $162 at Barclays
02/12/21 Citi
Alnylam downgraded to Neutral from Buy at Citi
BIIB Biogen
$270.07 /

-0.66 (-0.24%)

04/13/21 Roth Capital
Roth Capital sees Applied Genetic's XLRS licensing as vote of confidence
04/12/21 Oppenheimer
Sage Therapeutics data support 'enthusiasm' for SAGE-324 in ET, says Oppenheimer
04/12/21 Wedbush
Biogen price target raised to $245 from $236 at Wedbush
03/25/21 Piper Sandler
Piper says Biogen Tecfidera patents could change thesis, but sees unknowns
BMY Bristol-Myers
$65.46 /

+1.02 (+1.58%)

04/13/21 Truist
Bristol-Myers upgraded to Buy at Truist on improving pipeline asset visibility
04/13/21 Truist
Bristol-Myers upgraded to Buy from Hold at Truist
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/08/21 BofA
Gartner added to US 1 List, Bristol-Myers removed at BofA
BHVN Biohaven Pharmaceutical
$74.37 /

-1.435 (-1.89%)

03/11/21
Fly Intel: Top five analyst initiations
03/11/21 UBS
Biohaven Pharmaceutical initiated with a Buy at UBS
03/02/21 Mizuho
Biohaven Pharmaceutical price target raised to $103 from $93 at Mizuho
CPRX Catalyst Pharmaceuticals
$4.44 /

-0.02 (-0.45%)

03/16/21 Piper Sandler
Catalyst business continues to generate cash flow, says Piper Sandler
01/07/21 Piper Sandler
Piper says Catalyst's Firdapse commercial business performing as expected
01/06/21 Piper Sandler
Catalyst Firdapse commercial business performing as expected, says Piper Sandler
11/10/20 Piper Sandler
Catalyst Pharmaceuticals price target lowered to $5.50 from $6 at Piper Sandler
DGX Quest Diagnostics
$130.09 /

+0.86 (+0.67%)

03/12/21 Baird
Quest Diagnostics downgraded to Neutral from Outperform at Baird
01/29/21 Citi
Quest Diagnostics price target raised to $158 from $151 at Citi
12/17/20 Morgan Stanley
Morgan Stanley cuts Quest Diagnostics to Equal Weight ahead of 2022 slowdown
12/17/20 Morgan Stanley
Quest Diagnostics downgraded to Equal Weight from Overweight at Morgan Stanley
DNA Bought by RHHBY
$94.97 /

+ (+0.00%)

HZNP Horizon Therapeutics
$93.25 /

-0.32 (-0.34%)

03/25/21 Guggenheim
Horizon Therapeutics price target raised to $120 from $115 at Guggenheim
03/22/21
Fly Intel: Top five analyst initiations
03/22/21 Morgan Stanley
Horizon Therapeutics resumed with an Overweight at Morgan Stanley
03/18/21 Citi
Horizon Therapeutics price target raised to $120 from $116 at Citi
LIVN LivaNova
$81.37 /

-1.46 (-1.76%)

04/13/21 Piper Sandler
LivaNova price target raised to $92 from $81 at Piper Sandler
03/03/21
Fly Intel: Top five analyst downgrades
03/03/21 Berenberg
Berenberg cuts LivaNova EPS forecasts on investments, downgrades to Hold
03/03/21 Berenberg
LivaNova downgraded to Hold from Buy at Berenberg
LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

04/12/21 Benchmark
Benchmark sees full FDA approval of Regeneron's REGEN-COV coming
04/06/21 JPMorgan
JPMorgan survey 'broadly positive' on Eli Lilly Alzheimer's drug
03/24/21 BMO Capital
AbCellera price target lowered to $59 from $61 at BMO Capital
03/17/21 Mizuho
AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho
MDT Medtronic
$125.91 /

+0.06 (+0.05%)

04/15/21 Atlantic Equities
Atlantic Equities starts Medtronic at Overweight
04/15/21 Atlantic Equities
Medtronic initiated with an Overweight at Atlantic Equities
04/05/21 Citi
Citi opens positive catalyst watches on four medical supply stocks
02/24/21 Cowen
Medtronic price target raised to $135 from $120 at Cowen
NVS Novartis
$88.02 /

+0.81 (+0.93%)

04/05/21 Morgan Stanley
Regenxbio AAV9 patent challenged by Passage Bio, says Morgan Stanley
03/23/21 Societe Generale
Novartis price target raised to CHF 107 from CHF 104 at Societe Generale
03/22/21 Bernstein
Novartis initiated with a Market Perform at Bernstein
03/10/21
Fly Intel: Top five analyst downgrades
NVTA Invitae
$37.65 /

-1.47 (-3.76%)

04/05/21 Oppenheimer
Oppenheimer upgrades Invitae on valuation, sees potential high $50s stock
04/05/21 Oppenheimer
Invitae upgraded to Outperform from Perform at Oppenheimer
02/18/21 Ladenburg
Invitae upgraded to Buy with $58 price target at Ladenburg
02/18/21 Ladenburg
Invitae upgraded to Buy from Neutral at Ladenburg
PFE Pfizer
$38.57 /

+0.96 (+2.55%)

04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
04/09/21
Pfizer to host conference call
04/06/21 RBC Capital
Pfizer transferred with a Sector Perform at RBC Capital
PTCT PTC Therapeutics
$48.48 /

+0.33 (+0.69%)

03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform from Underperform at RBC Capital
02/26/21 Cantor Fitzgerald
PTC Therapeutics price target lowered to $75 from $81 at Cantor Fitzgerald
02/12/21 BofA
PTC Therapeutics downgraded to Neutral from Buy at BofA
RETA Reata Pharmaceuticals
$90.83 /

-1.29 (-1.40%)

11/25/20 Citi
Reata Pharmaceuticals price target lowered to $234 from $260 at Citi
11/10/20 Cantor Fitzgerald
Reata Pharmaceuticals price target raised to $220 from $169 at Cantor Fitzgerald
11/10/20 Citi
Reata Pharmaceuticals price target raised to $260 from $244 at Citi
08/11/20 Cantor Fitzgerald
Reata Pharmaceuticals price target lowered to $169 from $275 at Cantor Fitzgerald
SNY Sanofi
$51.29 /

+0.63 (+1.24%)

04/06/21 Barclays
Sanofi price target raised to EUR 85 from EUR 80 at Barclays
02/23/21 BofA
BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list
02/10/21 Morgan Stanley
Sanofi price target raised to EUR 104 from EUR 101 at Morgan Stanley
02/05/21 Piper Sandler
Piper reiterates Overweight on Kymera after Sanofi capital markets day
SUPN Supernus
$31.72 /

-0.09 (-0.28%)

04/13/21 Jefferies
Supernus upgraded to Buy after survey work at Jefferies
04/13/21 Jefferies
Supernus upgraded to Buy from Hold at Jefferies
02/03/21 Piper Sandler
Supernus price target raised to $35 from $30 at Piper Sandler
06/16/20 Piper Sandler
Supernus upgraded to Overweight from Neutral at Piper Sandler
TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

09:04 Today JPMorgan
Takeda Pharmaceutical downgraded to Neutral on R&D investments at JPMorgan
09:00 Today JPMorgan
Takeda Pharmaceutical downgraded to Neutral from Overweight at JPMorgan
04/15/21 Oppenheimer
Molecular Templates price target lowered to $13 from $18 at Oppenheimer
04/05/21
Fly Intel: Top five analyst downgrades
TEVA Teva
$10.75 /

-0.08 (-0.74%)

04/06/21 RBC Capital
Teva transferred with a Sector Perform at RBC Capital
01/26/21 Piper Sandler
Amarin in 'strong position' against Health Net, says Piper Sandler
12/21/20 Gabelli
Teva named 'Best Idea for 2021' at Gabelli
11/27/20 H.C. Wainwright
Corcept Therapeutics price target raised to $32 from $22 at H.C. Wainwright
TGTX TG Therapeutics
$44.79 /

-1.05 (-2.29%)

07:12 Today Cantor Fitzgerald
TG Therapeutics price target raised to $74 from $68 at Cantor Fitzgerald
06:14 Today H.C. Wainwright
TG Therapeutics price target raised to $89 from $79 at H.C. Wainwright
03/04/21 B. Riley
TG Therapeutics price target lowered to $91 from $95 at B. Riley Securities
02/09/21 B. Riley
TG Therapeutics price target raised to $95 from $90 at B. Riley Securities
ZGNX Zogenix
$19.00 /

-0.65 (-3.31%)

04/06/21 Evercore ISI
Evercore starts 'compelling' Arena spinoff Longboard at Outperform
04/06/21 Citi
Longboard Pharmaceuticals initiated with a Buy at Citi
02/03/21 Mizuho
Jazz deal for GW Pharma has positive read through to Zogenix, says Mizuho
12/04/20 Mizuho
Zogenix collaboration step in right direction, says Mizuho
AVDL Avadel Pharmaceuticals
$8.65 /

+0.09 (+1.05%)

03/10/21 H.C. Wainwright
Avadel Pharmaceuticals price target raised to $17 from $15 at H.C. Wainwright
01/25/21 Craig-Hallum
Avadel Pharmaceuticals assumed with a Buy rating at Craig-Hallum
08/28/20 Oppenheimer
Uwarranted pressure creates buying opportunity for Avadel, says Oppenheimer
08/28/20 SVB Leerink
Avadel selloff on Jazz competition worries overdone, says SVB Leerink
JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

09:14 Today Chardan
Chardan sees J&J moving forward with Emergent if observations are minor
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
ZGNX Zogenix
$19.00 /

-0.65 (-3.31%)

TGTX TG Therapeutics
$44.79 /

-1.05 (-2.29%)

TEVA Teva
$10.75 /

-0.08 (-0.74%)

TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

SUPN Supernus
$31.72 /

-0.09 (-0.28%)

SNY Sanofi
$51.29 /

+0.63 (+1.24%)

RETA Reata Pharmaceuticals
$90.83 /

-1.29 (-1.40%)

PTCT PTC Therapeutics
$48.48 /

+0.33 (+0.69%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

NVTA Invitae
$37.65 /

-1.47 (-3.76%)

NVS Novartis
$88.02 /

+0.81 (+0.93%)

MDT Medtronic
$125.91 /

+0.06 (+0.05%)

LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

LIVN LivaNova
$81.37 /

-1.46 (-1.76%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

HZNP Horizon Therapeutics
$93.25 /

-0.32 (-0.34%)

DGX Quest Diagnostics
$130.09 /

+0.86 (+0.67%)

CPRX Catalyst Pharmaceuticals
$4.44 /

-0.02 (-0.45%)

BMY Bristol-Myers
$65.46 /

+1.02 (+1.58%)

BIIB Biogen
$270.07 /

-0.66 (-0.24%)

BHVN Biohaven Pharmaceutical
$74.37 /

-1.435 (-1.89%)

AVDL Avadel Pharmaceuticals
$8.65 /

+0.09 (+1.05%)

ALNY Alnylam
$138.69 /

-0.23 (-0.17%)

ACAD Acadia Pharmaceuticals
$21.17 /

-0.02 (-0.09%)

ABT Abbott
$124.37 /

+0.4 (+0.32%)

ABC AmerisourceBergen
$119.62 /

+0.55 (+0.46%)

ABBV AbbVie
$107.93 /

+1.05 (+0.98%)

  • 16
    Mar
  • 22
    Jan
  • 15
    Dec
  • 02
    Dec
  • 07
    Aug
  • 15
    May
  • 29
    Apr
TEVA Teva
$10.75 /

-0.08 (-0.74%)

SNY Sanofi
$51.29 /

+0.63 (+1.24%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

NVS Novartis
$88.02 /

+0.81 (+0.93%)

LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

LIVN LivaNova
$81.37 /

-1.46 (-1.76%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

BMY Bristol-Myers
$65.46 /

+1.02 (+1.58%)

BIIB Biogen
$270.07 /

-0.66 (-0.24%)

ALNY Alnylam
$138.69 /

-0.23 (-0.17%)

ABT Abbott
$124.37 /

+0.4 (+0.32%)

ABC AmerisourceBergen
$119.62 /

+0.55 (+0.46%)

ABBV AbbVie
$107.93 /

+1.05 (+0.98%)

ZGNX Zogenix
$19.00 /

-0.65 (-3.31%)

TGTX TG Therapeutics
$44.79 /

-1.05 (-2.29%)

TEVA Teva
$10.75 /

-0.08 (-0.74%)

TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

SUPN Supernus
$31.72 /

-0.09 (-0.28%)

SNY Sanofi
$51.29 /

+0.63 (+1.24%)

RETA Reata Pharmaceuticals
$90.83 /

-1.29 (-1.40%)

PTCT PTC Therapeutics
$48.48 /

+0.33 (+0.69%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

NVTA Invitae
$37.65 /

-1.47 (-3.76%)

NVS Novartis
$88.02 /

+0.81 (+0.93%)

LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

HZNP Horizon Therapeutics
$93.25 /

-0.32 (-0.34%)

DGX Quest Diagnostics
$130.09 /

+0.86 (+0.67%)

CPRX Catalyst Pharmaceuticals
$4.44 /

-0.02 (-0.45%)

BMY Bristol-Myers
$65.46 /

+1.02 (+1.58%)

BIIB Biogen
$270.07 /

-0.66 (-0.24%)

BHVN Biohaven Pharmaceutical
$74.37 /

-1.435 (-1.89%)

AVDL Avadel Pharmaceuticals
$8.65 /

+0.09 (+1.05%)

ACAD Acadia Pharmaceuticals
$21.17 /

-0.02 (-0.09%)

ABT Abbott
$124.37 /

+0.4 (+0.32%)

ABC AmerisourceBergen
$119.62 /

+0.55 (+0.46%)

ABBV AbbVie
$107.93 /

+1.05 (+0.98%)

ZGNX Zogenix
$19.00 /

-0.65 (-3.31%)

TGTX TG Therapeutics
$44.79 /

-1.05 (-2.29%)

TEVA Teva
$10.75 /

-0.08 (-0.74%)

TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

NVTA Invitae
$37.65 /

-1.47 (-3.76%)

MDT Medtronic
$125.91 /

+0.06 (+0.05%)

LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

HZNP Horizon Therapeutics
$93.25 /

-0.32 (-0.34%)

DGX Quest Diagnostics
$130.09 /

+0.86 (+0.67%)

BMY Bristol-Myers
$65.46 /

+1.02 (+1.58%)

BIIB Biogen
$270.07 /

-0.66 (-0.24%)

ABT Abbott
$124.37 /

+0.4 (+0.32%)

ABC AmerisourceBergen
$119.62 /

+0.55 (+0.46%)

ABBV AbbVie
$107.93 /

+1.05 (+0.98%)

Hot Stocks
Zoom Video announces $100M Zoom Apps Fund » 09:21
04/19/21
04/19
09:21
04/19/21
09:21
ZM

Zoom Video

$329.97 /

-2.18 (-0.66%)

Zoom Video Communications…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZM Zoom Video
$329.97 /

-2.18 (-0.66%)

ZM Zoom Video
$329.97 /

-2.18 (-0.66%)

03/31/21
Fly Intel: Top five analyst initiations
03/31/21 Daiwa
Daiwa starts Zoom Video with Sell on risk from fading Covid tailwinds
03/30/21 Daiwa
Zoom Video initiated with a Sell at Daiwa
03/26/21
Fly Intel: Top five analyst initiations
ZM Zoom Video
$329.97 /

-2.18 (-0.66%)

  • 13
    Jan
ZM Zoom Video
$329.97 /

-2.18 (-0.66%)

ZM Zoom Video
$329.97 /

-2.18 (-0.66%)

ZM Zoom Video
$329.97 /

-2.18 (-0.66%)

Recommendations
Chardan sees J&J moving forward with Emergent if observations are minor » 09:14
04/19/21
04/19
09:14
04/19/21
09:14
EBS

Emergent BioSolutions

$77.65 /

+3.07 (+4.12%)

, JNJ

Johnson & Johnson

$162.24 /

+1.74 (+1.08%)

Chardan analyst Keay…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

EBS Emergent BioSolutions
$77.65 /

+3.07 (+4.12%)

EBS Emergent BioSolutions
$77.65 /

+3.07 (+4.12%)

04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/07/21
Fly Intel: Top five analyst initiations
04/07/21 Benchmark
Benchmark starts Emergent at Buy, thinks shares can resume upward momentum
04/07/21 Benchmark
Emergent BioSolutions initiated with a Buy at Benchmark
JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

EBS Emergent BioSolutions
$77.65 /

+3.07 (+4.12%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

EBS Emergent BioSolutions
$77.65 /

+3.07 (+4.12%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

EBS Emergent BioSolutions
$77.65 /

+3.07 (+4.12%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

Hot Stocks
Target launches new installment of Designer Dress Collection » 09:10
04/19/21
04/19
09:10
04/19/21
09:10
TGT

Target

$208.51 /

+2.76 (+1.34%)

Target announced a new…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TGT Target
$208.51 /

+2.76 (+1.34%)

TGT Target
$208.51 /

+2.76 (+1.34%)

07:31 Today JPMorgan
Target price target raised to $230 from $210 at JPMorgan
03/31/21 Guggenheim
Target price target raised to $225 from $200 at Guggenheim
03/30/21 Stifel
Target price target raised to $230 from $220 at Stifel
03/16/21 MKM Partners
Target price target raised to $170 from $156 at MKM Partners
TGT Target
$208.51 /

+2.76 (+1.34%)

TGT Target
$208.51 /

+2.76 (+1.34%)

TGT Target
$208.51 /

+2.76 (+1.34%)

TGT Target
$208.51 /

+2.76 (+1.34%)

Hot Stocks
Emergent stops manufacturing at Baltimore facility after FDA inspection » 09:04
04/19/21
04/19
09:04
04/19/21
09:04
EBS

Emergent BioSolutions

$77.65 /

+3.07 (+4.12%)

, JNJ

Johnson & Johnson

$162.24 /

+1.74 (+1.08%)

, AZN

AstraZeneca

$50.74 /

-0.1 (-0.20%)

Emergent BioSolutions…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

EBS Emergent BioSolutions
$77.65 /

+3.07 (+4.12%)

AZN AstraZeneca
$50.74 /

-0.1 (-0.20%)

EBS Emergent BioSolutions
$77.65 /

+3.07 (+4.12%)

04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/07/21
Fly Intel: Top five analyst initiations
04/07/21 Benchmark
Benchmark starts Emergent at Buy, thinks shares can resume upward momentum
04/07/21 Benchmark
Emergent BioSolutions initiated with a Buy at Benchmark
JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
AZN AstraZeneca
$50.74 /

-0.1 (-0.20%)

04/12/21
Fly Intel: Top five analyst downgrades
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
04/12/21 Argus
AstraZeneca downgraded to Hold from Buy at Argus
JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

EBS Emergent BioSolutions
$77.65 /

+3.07 (+4.12%)

AZN AstraZeneca
$50.74 /

-0.1 (-0.20%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

EBS Emergent BioSolutions
$77.65 /

+3.07 (+4.12%)

AZN AstraZeneca
$50.74 /

-0.1 (-0.20%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

EBS Emergent BioSolutions
$77.65 /

+3.07 (+4.12%)

AZN AstraZeneca
$50.74 /

-0.1 (-0.20%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

AZN AstraZeneca
$50.74 /

-0.1 (-0.20%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.